English source-aligned edition
Carl Clauberg
Carl Clauberg served as gynaecologist who conducted mass-sterilisation experiments on prisoners. The profile reconstructs the person’s function in Auschwitz and Ravensbrück concentration camps through documented office, decisions, supervision or operational conduct. It does not assign every crime committed by an institution or region to one individual.
Confirmed findings
- Clauberg proposed to Himmler in 1942 that he develop a cheap non-surgical method for mass sterilisation without the victims' knowledge.
- With Himmler's approval he used imprisoned women in Block 10 at Auschwitz for coercive sterilisation experiments.
- His work was explicitly framed as a method that could sterilise very large numbers of people and formed part of the regime's policy of biological destruction.
Place in the chain of responsibility
Clauberg used specialist authority and direct access to SS leadership to turn involuntary experimentation into a proposed population policy. The profile separates his programme from experiments by Mengele, Schumann and other doctors.
Key events and mechanisms
- proposal to Himmler for mass sterilisation, 1942
- experiments on imprisoned women in Auschwitz Block 10
- Soviet conviction and twenty-five-year sentence after 1945
The circle records authority, function and agency. Several profiles may describe different parts of the same persecution chain, so profile-level totals must not be added together.
Postwar accountability
A Soviet court sentenced Clauberg to twenty-five years, but he returned to West Germany under the 1955 repatriation arrangements. Public protests led to a new arrest and preparation of a West German prosecution; he died in Kiel prison on 9 August 1957 before that trial began.
Limits of the evidence
The profile distinguishes the completed Soviet proceeding from the West German case that never reached trial and avoids merging Clauberg's experiments with those of other Auschwitz physicians.
Sources
The source set combines institutional, archival, trial or scholarly material from at least two independent publishers.